Fenfluramine Augmentation of Clomipramine Treatment of Obsessive Compulsive Disorder
- 1 September 1991
- journal article
- other
- Published by SAGE Publications in Australian & New Zealand Journal of Psychiatry
- Vol. 25 (3) , 412-414
- https://doi.org/10.3109/00048679109062643
Abstract
Recently, much research interest has been directed to demonstrating a possible biological basis to obsessive compulsive disorder. In particular, dys-regulation in brain serotonin is suggested to be important. Two cases are described in which fenfluramine, a presynaptic 5 HT-releasing agent and 5HT-reuptake inhibitor was used to augment clomipramine treatment for OCD.Keywords
This publication has 11 references indexed in Scilit:
- Signs of Central Nervous System Dysfunction in Obsessive-Compulsive DisorderArchives of General Psychiatry, 1990
- Open trial of fluoxetine in obsessive-compulsive disorderAmerican Journal of Psychiatry, 1989
- Efficacy of Fluvoxamine in Obsessive-Compulsive DisorderArchives of General Psychiatry, 1989
- Clomipramine in Obsessive-Compulsive DisorderArchives of General Psychiatry, 1989
- The Epidemiology of Obsessive-Compulsive Disorder in Five US CommunitiesArchives of General Psychiatry, 1988
- Serotonergic and noradrenergic sensitivity in obsessive-compulsive disorder: behavioral findingsAmerican Journal of Psychiatry, 1988
- Serotonergic Responsivity in Obsessive-Compulsive DisorderArchives of General Psychiatry, 1987
- D- and L-isomers of fenfluramine differ markedly in their interaction with brain serotonin and catecholamines in the ratEuropean Journal of Pharmacology, 1986
- The Psychopharmacological Treatment of Obsessive-Compulsive DisorderJournal of Clinical Psychopharmacology, 1981
- Behavioral evidence for the rapid release of CNS serotonin by PCA and fenfluramineEuropean Journal of Pharmacology, 1976